LabTurbo Biotech Corporation

NT$21.00As of Sun 8 Nov 2026, 12:00 UTC

TPEx:7725Healthcare

Country Taiwan

PE (Fwd) 144.1

TSR 3Y CAGR (15.34%)

Div yield —

ROE —

Biotechnology

Beta (5Y) —

PE TTM —

TSR TTM (15.30%)

Mkt cap NT$1.007B

ROIC —

SE Grade™

—

Value

—

Quality

Moat

1Y Price

Reference

NT$22

—

5.36%

—

TTM

FYE 31 Dec TWD

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026E

Trend

10Y

Peers

—

RevenueNT$B

—

0.979

1.342

0.188

0.073

—

0.046

(57.92%)

—

Revenue growth%

—

37.03

(85.99)

(61.20)

—

(37.13)

(61.20)

—

Gross margin%

—

69.88

74.17

16.55

23.33

—

23.73

46.60

—

Operating margin%

—

59.64

59.49

(95.03)

(250.10)

—

(100.00)

(17.77)

—

Net margin%

—

46.81

47.89

(34.21)

17.76

—

17.86

32.29

—

P/E ratio (avg)x

—

110.6

—

122.8

110.6

—

EV/EBITx

—

FCF yield (avg)%

—

(9.80)

—

(4.56)

(9.80)

—

FCF margin%

—

13.40

59.71

(93.74)

(192.51)

—

(100.00)

(40.17)

—

FCF / Net incomex

—

0.286

1.247

2.740

(10.84)

—

(5.598)

0.766

—

ROIC%

—

114.86

116.88

(18.72)

(16.45)

—

(3.60)

49.20

—

Return on equity%

—

43.23

49.50

(4.48)

0.98

—

0.62

22.10

—

Return on assets%

—

33.59

36.18

(4.59)

0.93

—

0.58

17.26

—

EPSNT$

—

13.10

(1.33)

0.27

—

0.17

(85.65%)

—

EPS growth%

—

(110.16)

120.25

—

5.05

—

Bookvalue per shNT$

—

31.32

27.64

27.32

—

27.74

(6.60%)

—

FCF per shareNT$

—

16.34

(3.65)

(2.92)

—

(0.96)

—

Dividend per shNT$

—

Div yield (avg)%

—

Payout ratio%

—

47.94

Shares (diluted)M

—

49.05

48.33

48.07

47.94

◌47.94

(0.76%)

—

0.27

Buyback yield%

—

1.48

0.53

0.27

◌—

0.53

—

D/E ratiox

—

0.050

0.023

—

0.021

—

0.021

0.022

—

1.007

Enterprise valueNT$B

—

1.287

1.197

0.951

(6.92%)

—

LT debtNT$M

—

43.74

21.72

—

(50.34%)

—

Peers (US$30.51M)

Cap (US$)

Bio Preventive…

30.17M

—

Enimmune Corporation

29.85M

—

Level Biotechnology…

29.70M

15.30x

Sharp Therapeutics…

30.62M

—

Capital

TTM

10Y

Leveragex

—

(0.861)

EBIT/Intx

—

214.6

Own earn%

—

Sh yield%

0.27

0.53

Owners

Insiders/Inst%

86.67

0.69

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

3/4

Revenue growth years

1/3

EPS growth years

—

Dividend streakyrs

Op margin range%

−250–60

$1 testx

—

Incr. ROIC%

—

LabTurbo Biotech Corporation engages in the research, manufacture, and sale of gene detection systems and kits in Taiwan, the United States, the Czech Republic, Spain, France, Israel, Singapore, the Philippines, and Malaysia. It serves hospitals. The company was founded in 2000 and is based in Taipei, Taiwan.

Revenue by segment

No breakdown available

Revenue by region

No breakdown available

Reinvestment returns

No breakdown available